114
Views
0
CrossRef citations to date
0
Altmetric
Review

Translating Genomic Analyses into Improved Management of Coronary Artery Disease

, &
Pages 507-521 | Published online: 07 Jul 2010

Bibliography

  • Roy H , BhardwajS, Yla-HerttualaS: Molecular genetics of atherosclerosis.Hum. Genet.125(5–6) , 467–491 (2009).
  • Lusis AJ , FogelmanAM, FonarowGC: Genetic basis of atherosclerosis: part I: new genes and pathways.Circulation110(13) , 1868–1873 (2004).
  • Yamada Y , IchiharaS, NishidaT: Molecular genetics of myocardial infarction.Genomic Med.2(1–2) , 7–22 (2008).
  • Tousoulis D , BriasoulisA, PapageorgiouN, AntoniadesC, StefanadisC: Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.Trends Mol. Med.14(10) , 441–449 (2008).
  • Hegele RA : SNP judgments and freedom of association.Arterioscler. Thromb. Vasc. Biol.22(7) , 1058–1061 (2002).
  • Lander ES , LintonLM, BirrenBet al.: Initial sequencing and analysis of the human genome.Nature409(6822) , 860–921 (2001).
  • Frazer KA , BallingerDG, CoxDRet al.: A second generation human haplotype map of over 3.1 million SNPs.Nature449(7164) , 851–861 (2007).
  • Conrad DF , PintoD, RedonRet al.: Origins and functional impact of copy number variation in the human genome.Nature464(7289) , 704–712 (2010).
  • Frazer KA , MurraySS, SchorkNJ, TopolEJ: Human genetic variation and its contribution to complex traits.Nat. Rev. Genet.10(4) , 241–251 (2009).
  • Hurles ME , DermitzakisET, Tyler-SmithC: The functional impact of structural variation in humans.Trends Genet.24(5) , 238–245 (2008).
  • Redon R , IshikawaS, FitchKRet al.: Global variation in copy number in the human genome.Nature444(7118) , 444–454 (2006).
  • Attia J , IoannidisJP, ThakkinstianAet al.: How to use an article about genetic association: A: background concepts.JAMA301(1) , 74–81 (2009).
  • Attia J , IoannidisJP, ThakkinstianAet al.: How to use an article about genetic association: B: are the results of the study valid?JAMA301(2) , 191–197 (2009).
  • Attia J , IoannidisJP, ThakkinstianAet al.: How to use an article about genetic association: C: what are the results and will they help me in caring for my patients?JAMA301(3) , 304–308 (2009).
  • Reich DE , LanderES: On the allelic spectrum of human disease.Trends Genet.17(9) , 502–510 (2001).
  • Pritchard JK : Are rare variants responsible for susceptibility to complex diseases?Am. J. Hum. Genet.69(1) , 124–137 (2001).
  • Schork NJ , MurraySS, FrazerKA, TopolEJ: Common vs. rare allele hypotheses for complex diseases.Curr. Opin. Genet. Dev.19(3) , 212–219 (2009).
  • International HapMap Consortium: The international HapMap project. Nature426(6968) , 789–796 (2003).
  • Pearson TA , ManolioTA: How to interpret a genome-wide association study.JAMA299(11) , 1335–1344 (2008).
  • McPherson R , PertsemlidisA, KavaslarNet al.: A common allele on chromosome 9 associated with coronary heart disease.Science316(5830) , 1488–1491 (2007).
  • Helgadottir A , ThorleifssonG, ManolescuAet al.: A common variant on chromosome 9p21 affects the risk of myocardial infarction.Science316(5830) , 1491–1493 (2007).
  • Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature447(7145) , 661–678 (2007).
  • Broadbent HM , PedenJF, LorkowskiSet al.: Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.Hum. Mol. Genet.17(6) , 806–814 (2008).
  • Holdt LM , BeutnerF, ScholzMet al.: ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.Arterioscler. Thromb. Vasc. Biol.30(3) , 620–627 (2010).
  • Jarinova O , StewartAF, RobertsRet al.: Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.Arterioscler. Thromb. Vasc. Biol.29(10) , 1671–1677 (2009).
  • Visel A , ZhuY, MayDet al.: Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.Nature464(7287) , 409–412 (2010).
  • Samani NJ , ErdmannJ, HallASet al.: Genome-wide association analysis of coronary artery disease.N. Engl. J. Med.357(5) , 443–453 (2007).
  • Helgadottir A , ThorleifssonG, MagnussonKPet al.: The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.Nat. Genet.40(2) , 217–224 (2008).
  • Schunkert H , GotzA, BraundPet al.: Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease.Circulation117(13) , 1675–1684 (2008).
  • Ye S , WilleitJ, KronenbergF, XuQ, KiechlS: Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study.J. Am. Coll. Cardiol.52(5) , 378–384 (2008).
  • Thompson AR , GolledgeJ, CooperJAet al.: Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion.Eur. J. Hum. Genet.17(3) , 391–394 (2009).
  • Abdullah KG , LiL, ShenGQet al.: Four SNPs on chromosome 9p21 confer risk to premature, familial CAD and MI in an American Caucasian population (GeneQuest).Ann. Hum. Genet.72(Pt 5) , 654–657 (2008).
  • Muendlein A , SaelyCH, RhombergSet al.: Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease.Atherosclerosis205(1) , 174–180 (2009).
  • Shen GQ , LiL, RaoSet al.: Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease.Arterioscler. Thromb. Vasc. Biol.28(2) , 360–365 (2008).
  • Shen GQ , RaoS, MartinelliNet al.: Association between four SNPSs on chromosome 9p21 and myocardial infarction is replicated in an Italian population.J. Hum. Genet.53(2) , 144–150 (2008).
  • Zhou L , ZhangX, HeMet al.: Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population.Arterioscler. Thromb. Vasc. Biol.28(11) , 2085–2089 (2008).
  • Assimes TL , KnowlesJW, BasuAet al.: Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic advance study.Hum. Mol. Genet.17(15) , 2320–2328 (2008).
  • Teo YY , SmallKS, KwiatkowskiDP: Methodological challenges of genome-wide association analysis in Africa.Nat. Rev. Genet.11(2) , 149–160 (2010).
  • Cluett C , McDermottMM, GuralnikJet al.: The 9p21 myocardial infarction risk allele increases risk of peripheral artery disease in older people.Circ. Cardiovasc. Genet.2(4) , 347–353 (2009).
  • Bjorck HM , LanneT, AlehagenUet al.: Association of genetic variation on chromosome 9p21.3 and arterial stiffness.J. Intern. Med.265(3) , 373–381 (2009).
  • Lemmens R , AbboudS, RobberechtWet al.: Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke.Eur. J. Hum. Genet.17(10) , 1287–1293 (2009).
  • Samani NJ , RaitakariOT, SipilaKet al.: Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis.Arterioscler. Thromb. Vasc. Biol.28(9) , 1679–1683 (2008).
  • Wahlstrand B , Orho-MelanderM, DellingLet al.: The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.J. Hypertens.27(4) , 769–773 (2009).
  • Karvanen J , SilanderK, KeeFet al.: The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts.Genet. Epidemiol.33(3) , 237–246 (2009).
  • Cunnington MS , MayosiBM, HallDHet al.: Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima–media thickness or intermediate risk phenotypes.Atherosclerosis203(1) , 41–44 (2009).
  • Smith JG , MelanderO, LovkvistHet al.: Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study.Circ. Cardiovasc. Genet.2(2) , 159–164 (2009).
  • Lanktree MB , HegeleRA, YusufS, AnandSS: Multi-ethnic genetic association study of carotid intima–media thickness using a targeted cardiovascular SNP microarray.Stroke40(10) , 3173–3179 (2009).
  • Kathiresan S , VoightBF, PurcellSet al.: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.Nat. Genet.41(3) , 334–341 (2009).
  • Willer CJ , SannaS, JacksonAUet al.: Newly identified loci that influence lipid concentrations and risk of coronary artery disease.Nat. Genet.40(2) , 161–169 (2008).
  • Linsel-Nitschke P , HeerenJ, AherrahrouZet al.: Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.Atherosclerosis208(1) , 183–189 (2010).
  • Jansen P , GiehlK, NyengaardJRet al.: Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury.Nat. Neurosci.10(11) , 1449–1457 (2007).
  • Nielsen MS , JacobsenC, OlivecronaG, GliemannJ, PetersenCM: Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase.J. Biol. Chem.274(13) , 8832–8836 (1999).
  • Nilsson SK , ChristensenS, RaarupMKet al.: Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families.J. Biol. Chem.283(38) , 25920–25927 (2008).
  • Schadt EE , MolonyC, ChudinEet al.: Mapping the genetic architecture of gene expression in human liver.PLoS Biol.6(5) , E107 (2008).
  • Hegele RA : Plasma lipoproteins: genetic influences and clinical implications.Nat. Rev. Genet.10(2) , 109–121 (2009).
  • Cohen JC , BoerwinkleE, MosleyTH Jr, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med.354(12) , 1264–1272 (2006).
  • Erdmann J , GrosshennigA, BraundPSet al.: New susceptibility locus for coronary artery disease on chromosome 3q22.3.Nat. Genet.41(3) , 280–282 (2009).
  • Kathiresan S , WillerCJ, PelosoGMet al.: Common variants at 30 loci contribute to polygenic dyslipidemia.Nat. Genet.41(1) , 56–65 (2009).
  • Tregouet DA , KonigIR, ErdmannJet al.: Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.Nat. Genet.41(3) , 283–285 (2009).
  • Kamstrup PR , BennM, Tybjaerg-HansenA, NordestgaardBG: Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.Circulation117(2) , 176–184 (2008).
  • Kamstrup PR , Tybjaerg-HansenA, SteffensenR, NordestgaardBG: Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.J. Clin. Endocrinol. Metab.93(10) , 3769–3776 (2008).
  • Erqou S , KaptogeS, PerryPLet al.: Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.JAMA302(4) , 412–423 (2009).
  • Koschinsky ML , MarcovinaSM: Structure–function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity.Curr. Opin. Lipidol.15(2) , 167–174 (2004).
  • Koschinsky ML : Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.Curr. Atheroscler. Rep.7(5) , 389–395 (2005).
  • Sharrett AR , BallantyneCM, CoadySAet al.: Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a) , apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study.Circulation104(10) , 1108–1113 (2001).
  • Lanktree MB , AnandSS, YusufS, HegeleRA: Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.Circ. Cardiovasc. Genet.3(1) , 39–46 (2010).
  • Boerwinkle E , LeffertCC, LinJet al.: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.J. Clin. Invest.90(1) , 52–60 (1992).
  • Kamstrup PR , Tybjaerg-HansenA, SteffensenR, NordestgaardBG: Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.JAMA301(22) , 2331–2339 (2009).
  • Clarke R , PedenJF, HopewellJCet al.: Genetic variants associated with LP(a) lipoprotein level and coronary disease.N. Engl. J. Med.361(26) , 2518–2528 (2009).
  • Samani NJ , DeloukasP, ErdmannJet al.: Large scale association analysis of novel genetic loci for coronary artery disease.Arterioscler. Thromb. Vasc. Biol.29(5) , 774–780 (2009).
  • Lanktree MB , HegeleRA: Gene–gene and gene–environment interactions: new insights into the prevention, detection and management of coronary artery disease.Genome Med.1(2) , 28 (2009).
  • Wilson PW , D‘AgostinoRB, LevyDet al.: Prediction of coronary heart disease using risk factor categories.Circulation97(18) , 1837–1847 (1998).
  • Ridker PM , BuringJE, RifaiN, CookNR: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.JAMA297(6) , 611–619 (2007).
  • Ridker PM , PaynterNP, RifaiN, GazianoJM, CookNR: C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.Circulation118(22) , 2243–2251, 2244P following 2251 (2008).
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA285(19) , 2486–2497 (2001).
  • Zethelius B , BerglundL, SundstromJet al.: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.N. Engl. J. Med.358(20) , 2107–2116 (2008).
  • Li S , ZhaoJH, LuanJet al.: Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies.Am. J. Clin. Nutr.91(1) , 184–190 (2010).
  • Lango H , PalmerCN, MorrisADet al.: Assessing the combined impact of 18 common genetic variants of modest effect sizes on Type 2 diabetes risk.Diabetes57(11) , 3129–3135 (2008).
  • Pencina MJ , D‘AgostinoRB Sr, D‘Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med.27(2) , 157–172; discussion 207–112 (2008).
  • Johansen CT , HegeleRA: Predictive genetic testing for coronary artery disease.Crit. Rev. Clin. Lab. Sci.46(5–6) , 343–360 (2009).
  • Paynter NP , ChasmanDI, BuringJEet al.: Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.Ann. Intern. Med.150(2) , 65–72 (2009).
  • Talmud PJ , CooperJA, PalmenJet al.: Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men.Clin. Chem.54(3) , 467–474 (2008).
  • Brautbar A , BallantyneCM, LawsonKet al.: Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the atherosclerosis risk in communities study.Circ. Cardiovasc. Genet.2(3) , 279–285 (2009).
  • Kathiresan S , MelanderO, AnevskiDet al.: Polymorphisms associated with cholesterol and risk of cardiovascular events.N. Engl. J. Med.358(12) , 1240–1249 (2008).
  • Arnett DK , BairdAE, BarkleyRAet al.: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.Circulation115(22) , 2878–2901 (2007).
  • Lloyd-Jones DM , NamBH, D‘AgostinoRB Sr et al.: Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA291(18) , 2204–2211 (2004).
  • Murabito JM , PencinaMJ, NamBHet al.: Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults.JAMA294(24) , 3117–3123 (2005).
  • Michos ED , VasamreddyCR, BeckerDMet al.: Women with a low Framingham Risk Score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis.Am. Heart J.150(6) , 1276–1281 (2005).
  • Taraboanta C , WuE, LearSet al.: Subclinical atherosclerosis in subjects with family history of premature coronary artery disease.Am. Heart J.155(6) , 1020.E1–1026.E1 (2008).
  • Choi JC , LeeJS, KangSY, KangJH, BaeJM: Family history and risk for ischemic stroke: sibling history is more strongly correlated with the disease than parental history.J. Neurol. Sci.284(1–2) , 29–32 (2009).
  • Nasir K , BudoffMJ, WongNDet al.: Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).Circulation116(6) , 619–626 (2007).
  • Wang TJ , NamBH, D‘AgostinoRBet al.: Carotid intima–media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study.Circulation108(5) , 572–576 (2003).
  • Myers RH , KielyDK, CupplesLA, KannelWB: Parental history is an independent risk factor for coronary artery disease: the Framingham Study.Am. Heart J.120(4) , 963–969 (1990).
  • Pencina MJ , D‘AgostinoRB Sr, Larson MG, Massaro JM, Vasan RS: Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation119(24) , 3078–3084 (2009).
  • Tuzcu EM , KapadiaSR, TutarEet al.: High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound.Circulation103(22) , 2705–2710 (2001).
  • Bennet AM , Di Angelantonio E, Ye Z et al.: Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA298(11) , 1300–1311 (2007).
  • Linsel-Nitschke P , GotzA, ErdmannJet al.: Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease – a Mendelian randomisation study.PLoS One3(8) , E2986 (2008).
  • Kraft P , HunterDJ: Genetic risk prediction – are we there yet?N. Engl. J. Med.360(17) , 1701–1703 (2009).
  • Metzker ML : Sequencing technologies – the next generation.Nat. Rev. Genet.11(1) , 31–46 (2010).
  • Cohen JC , PertsemlidisA, FahmiSet al.: Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.Proc. Natl Acad. Sci. USA103(6) , 1810–1815 (2006).
  • Cohen JC , KissRS, PertsemlidisAet al.: Multiple rare alleles contribute to low plasma levels of HDL cholesterol.Science305(5685) , 869–872 (2004).
  • Romeo S , PennacchioLA, FuYet al.: Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.Nat. Genet.39(4) , 513–516 (2007).
  • Romeo S , YinW, KozlitinaJet al.: Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.J. Clin. Invest.119(1) , 70–79 (2009).
  • Wang J , CaoH, BanMRet al.: Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650).Arterioscler. Thromb. Vasc. Biol.27(11) , 2450–2455 (2007).
  • Mangravite LM , WilkeRA, ZhangJ, KraussRM: Pharmacogenomics of statin response.Curr. Opin. Mol. Ther.10(6) , 555–561 (2008).
  • Pollex RL , HegeleRA: Copy number variation in the human genome and its implications for cardiovascular disease.Circulation115(24) , 3130–3138 (2007).
  • Tracy RP : ‘Deep phenotyping‘: characterizing populations in the era of genomics and systems biology.Curr. Opin. Lipidol.19(2) , 151–157 (2008).
  • Lanktree MB , HassellRG, LahiryP, HegeleRA: Phenomics: expanding the role of clinical evaluation in genomic studies.J. Investig. Med.58(5) , 700–706 (2010).
  • Davey Smith G , EbrahimS: ‘Mendelian randomization‘: can genetic epidemiology contribute to understanding environmental determinants of disease?Int. J. Epidemiol.32(1) , 1–22 (2003).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.